By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 23
NEW YORK (Reuters Health) – On May 8, a panel of advisers to the US Food and Drug Administration unanimously voted against rilonacept (Arcalyst, Regeneron Pharmaceuticals) for use…
NEW YORK (Reuters Health) – Patients with pulmonary arterial hypertension (PAH) receiving the endothelin A selective antagonist ambrisentan (Letairis, Gilead) no longer need monthly liver function tests. However,…
NEW YORK (Reuters Health) – Percutaneous endoscopic gastrostomy (PEG) feeding tubes do more harm than good in nursing home residents with advanced cognitive impairment, a propensity-matched cohort study…
NEW YORK (Reuters Health) – Regardless of dosage, frequency or route of administration, vitamin D3 (cholecalciferol) is more efficacious in raising serum 25 hydroxyvitamin D concentrations than vitamin…
NEW YORK (Reuters Health) – Three years after a group of women with stress urinary incontinence were treated with transobturator tension-free vaginal tape (TO-TVT), roughly three-quarters felt the…
NEW YORK (Reuters Health) – Orally administered dimenhydrinate does not reduce the frequency of vomiting in children with gastroenteritis, researchers from Canada report in the May 14th online…
NEW YORK (Reuters Health) – Preoperative 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) can make a significant contribution to staging for locally advanced gastric cancer, according to a report in…
NEW YORK (Reuters Health) – The combination of estrogen and raloxifene seems to reduce menopausal symptoms and appears not to increase the risk of endometrial hyperplasia, researchers from…
NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include…
NEW YORK (Reuters Health) – A program of patient education and planning aimed at treating exacerbations of chronic obstructive pulmonary disease early and reducing rates of hospitalization was…
